Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIA Pancreatic Adenocarcinoma”

59 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59 results

Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT04662112
What this trial is testing

Liposomal Irinotecan, S-1, and Oxaliplatin in Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic CancerPancreatic Ductal Adenocarcinoma
Asan Medical Center 40
Testing effectiveness (Phase 2)Looking for participantsNCT07235202
What this trial is testing

MR001 Combined With Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) After First-line Therapy

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
Shenzhen Majory Biotechnology Co., Ltd. 45
Early research (Phase 1)Active Not RecruitingNCT05034627
What this trial is testing

Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaStage II Pancreatic Cancer AJCC v8+4 more
OHSU Knight Cancer Institute 15
Testing effectiveness (Phase 2)Study completedNCT01959672
What this trial is testing

Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaResectable Pancreatic CarcinomaStage I Pancreatic Cancer+6 more
University of Nebraska 11
Early research (Phase 1)Not Yet RecruitingNCT07481357
What this trial is testing

A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma

Who this might be right for
Gastric (Stomach) CancerGastroEsophageal CancerPancreatic Ductal Adenocarcinoma (mPDAC)
Dong-A ST Co., Ltd. 51
Testing effectiveness (Phase 2)UnknownNCT04216758
What this trial is testing

Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic Cancer

Who this might be right for
Stage IA Pancreatic AdenocarcinomaStage IB Pancreatic AdenocarcinomaStage IIA Pancreatic Adenocarcinoma+1 more
Fudan University 300
Testing effectiveness (Phase 2)Ended earlyNCT01897454
What this trial is testing

Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaStage IIA Pancreatic CancerStage IIB Pancreatic Cancer+1 more
Albert Einstein College of Medicine 23
Testing effectiveness (Phase 2)WithdrawnNCT03432676
What this trial is testing

Epacadostat and Pembrolizumab in Treating Participants With Advanced Pancreatic Cancer

Who this might be right for
ATM Gene MutationDeleterious BRCA1 Gene MutationDeleterious BRCA2 Gene Mutation+7 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03077685
What this trial is testing

Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
NanOlogy, LLC 54
Testing effectiveness (Phase 2)Looking for participantsNCT04887805
What this trial is testing

Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8Stage IIA Pancreatic Cancer AJCC v8+4 more
City of Hope Medical Center 28
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Looking for participantsNCT06305247
What this trial is testing

Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours

Who this might be right for
MelanomaHead and Neck Squamous Cell CarcinomaPancreatic Ductal Adenocarcinoma+2 more
Ipsen 220
Testing effectiveness (Phase 2)Study completedNCT02005419
What this trial is testing

Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection

Who this might be right for
Stage IA Pancreatic AdenocarcinomaStage IB Pancreatic AdenocarcinomaStage IIA Pancreatic Adenocarcinoma+1 more
Xian-Jun Yu 300
Not applicableLooking for participantsNCT01365169
What this trial is testing

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Who this might be right for
Malignant Head and Neck NeoplasmMalignant NeoplasmMetastatic Malignant Neoplasm in the Neck+45 more
M.D. Anderson Cancer Center 590
Early research (Phase 1)Active Not RecruitingNCT04106856
What this trial is testing

Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (SHAPER)

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaLocally Advanced Unresectable Pancreatic Adenocarcinoma+4 more
University of Utah 22
Early research (Phase 1)Ended earlyNCT06599502
What this trial is testing

A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D Mutation

Who this might be right for
Advanced Solid TumoursNon-Small Cell Lung Cancer (NSCLC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
AstraZeneca 17
Not applicableStudy completedNCT04449679
What this trial is testing

Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study

Who this might be right for
Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage 0 Gastric Cancer AJCC v8+83 more
Thomas Jefferson University 34
Testing effectiveness (Phase 2)Looking for participantsNCT04657068
What this trial is testing

ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced CancerMetastatic CancerOvarian Cancer+6 more
Artios Pharma Ltd 442
Testing effectiveness (Phase 2)Study completedNCT01416662
What this trial is testing

Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

Who this might be right for
Pancreatic Cancer
Federation Francophone de Cancerologie Digestive 120
Load More Results